Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Relay Therapeutics (RLAY), a clinical-stage precision medicine company, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's President and CEO, Dr. Sanjiv Patel, will deliver a presentation on Tuesday, January 14, 2025, at 7:30 a.m. PT.
The presentation will be accessible through a live webcast on the company's website under the Events section in News & Events. Interested parties can access the webcast through the IR portal at ir.relaytx.com. An archived version of the presentation will remain available for 30 days after the event.
Relay Therapeutics specializes in transforming drug discovery by combining advanced computational and experimental technologies.
Relay Therapeutics (RLAY), un'azienda nel settore dei farmaci di precisione in fase clinica, ha annunciato la sua partecipazione alla 43ª Conferenza Sanitaria Annuale J.P. Morgan. Il Presidente e CEO dell'azienda, Dr. Sanjiv Patel, terrà una presentazione martedì 14 gennaio 2025, alle 7:30 a.m. PT.
La presentazione sarà disponibile tramite una diretta web sul sito dell'azienda nella sezione Eventi in Notizie & Eventi. Le parti interessate possono accedere alla diretta attraverso il portale IR su ir.relaytx.com. Una versione archiviata della presentazione rimarrà disponibile per 30 giorni dopo l'evento.
Relay Therapeutics si specializza nella trasformazione della scoperta di farmaci combinando tecnologie computazionali e sperimentali avanzate.
Relay Therapeutics (RLAY), una empresa de medicina de precisión en etapa clínica, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica J.P. Morgan. El Presidente y CEO de la empresa, Dr. Sanjiv Patel, realizará una presentación el martes 14 de enero de 2025, a las 7:30 a.m. PT.
La presentación estará disponible a través de una transmisión en vivo en el sitio web de la empresa en la sección de Eventos en Noticias y Eventos. Las partes interesadas pueden acceder a la transmisión a través del portal de IR en ir.relaytx.com. Una versión archivada de la presentación permanecerá disponible durante 30 días después del evento.
Relay Therapeutics se especializa en transformar el descubrimiento de medicamentos al combinar tecnologías computacionales y experimentales avanzadas.
릴레이 테라퓨틱스 (RLAY), 임상 단계의 정밀 의약품 회사가 제43회 JP모건 헬스케어 컨퍼런스에 참석할 것이라고 발표했습니다. 회사의 사장 겸 CEO인 Dr. Sanjiv Patel이 2025년 1월 14일 화요일 오전 7시 30분 PT에 발표를 진행할 예정입니다.
발표는 회사 웹사이트의 뉴스 및 이벤트 섹션의 이벤트 아래에서 라이브 웹캐스트를 통해 접근할 수 있습니다. 관심 있는 당사자는 ir.relaytx.com의 IR 포털을 통해 웹캐스트에 접속할 수 있습니다. 발표의 아카이브 버전은 이벤트 이후 30일간 이용 가능합니다.
릴레이 테라퓨틱스는 고급 컴퓨팅 및 실험 기술을 결합하여 의약품 발견을 혁신하는 데 전문성을 가지고 있습니다.
Relay Therapeutics (RLAY), une entreprise de médecine de précision en phase clinique, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan sur la Santé. Le Président et CEO de l'entreprise, Dr. Sanjiv Patel, présentera une communication mardi 14 janvier 2025, à 7h30 PT.
La présentation sera accessible via un webinaire en direct sur le site de l'entreprise dans la section Événements des Nouvelles & Événements. Les parties intéressées peuvent accéder au webinaire par le portail IR à ir.relaytx.com. Une version archivée de la présentation sera disponible pendant 30 jours après l'événement.
Relay Therapeutics se spécialise dans la transformation de la découverte de médicaments en combinant des technologies expérimentales et informatiques avancées.
Relay Therapeutics (RLAY), ein Unternehmen im Bereich der präzisen Medizin in der klinischen Phase, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Gesundheitskonferenz angekündigt. Der Präsident und CEO des Unternehmens, Dr. Sanjiv Patel, wird am Dienstag, den 14. Januar 2025, um 7:30 Uhr PT eine Präsentation halten.
Die Präsentation wird über einen Live-Stream auf der Website des Unternehmens im Bereich Veranstaltungen unter Nachrichten & Veranstaltungen zugänglich sein. Interessierte Parteien können auf den Live-Stream über das IR-Portal unter ir.relaytx.com zugreifen. Eine archivierte Version der Präsentation wird 30 Tage nach der Veranstaltung verfügbar bleiben.
Relay Therapeutics spezialisiert sich auf die Umwandlung der Arzneimittelentdeckung durch die Kombination fortschrittlicher rechnergestützter und experimenteller Technologien.
- None.
- None.
CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that Sanjiv Patel, M.D., President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 7:30 a.m. PT.
The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo® platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.
Contact:
Pete Rahmer
prahmer@relaytx.com
Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com
FAQ
When is Relay Therapeutics (RLAY) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors access Relay Therapeutics' (RLAY) J.P. Morgan Healthcare Conference presentation?
How long will Relay Therapeutics' (RLAY) J.P. Morgan presentation replay be available?
What is Relay Therapeutics' (RLAY) approach to drug discovery?
